Vaccination using peptides spanning the SYT–SSX tumor-specific translocation

SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: A study from the Japanese Musculoskeletal Oncology Group

(2012) Satoshi Kawaguchi et al.   CANCER SCIENCE

Antiangiogenic approaches for the treatment of advanced synovial sarcomas

(2012) Khanh Do et al.   CURRENT OPINION IN ONCOLOGY

Expression and Immunotherapeutic Targeting of the SSX Family of Cancer-Testis Antigens in Prostate Cancer

(2011) H. A. Smith et al.   CANCER RESEARCH

Type I interferon supports primary CD8+ T-cell responses to peptide-pulsed dendritic cells in the absence of CD4+ T-cell help

(2011) Fernando Ontiveros et al.   IMMUNOLOGY

Vaccines Targeting the Cancer-testis Antigen SSX-2 Elicit HLA-A2 Epitope-specific Cytolytic T Cells

(2011) Heath A. Smith et al.   JOURNAL OF IMMUNOTHERAPY

The SSX Family of Cancer-Testis Antigens as Target Proteins for Tumor Therapy

(2010) Heath A. Smith et al.   Clinical & Developmental Immunology

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

(2009) Celestia S. Higano et al.   CANCER

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

(2009) M. A. Cheever et al.   CLINICAL CANCER RESEARCH

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

(2009) J. D. Wolchok et al.   CLINICAL CANCER RESEARCH